Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II

Immunogenetics

Volumn 54, Issue 11, 2003, Pages 747-755

  Wiszniewski, Wojciech ^a,b   Fondaneche, Marie Claude ^a   Louise Plence, Pascale ^c   Prochnicka Chalufour, Ada ^d   Selz, Françoise ^a   Picard, Cappucine ^a   Deist, Françoise ^a   Eliaou, Jean François ^c   Fischer, Alain ^a   Lisowska Grospierre, Barbara ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSTITUTE OF MOTHER AND CHILD   (Poland)

^c INSERM   (France)

^d CNRS   (France)

Author keywords

Ankyrin repeat; MHC II; RFXANK; Transcription

Indexed keywords

ANKYRIN; GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN CIITA; PROTEIN RFX5; PROTEIN RFXANK; PROTEIN RFXAP; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIGEN DETECTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; COMPLEX FORMATION; DNA BINDING; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; GENETIC CODE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MISSENSE MUTATION; NULL ALLELE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN INTERACTION; RFXANK GENE; STRUCTURE ANALYSIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; WILD TYPE;

EID: 0037304181     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-002-0521-1     Document Type: Article

References (23)

1. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W and Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402
2. Batchelor AH, Piper DE, de la Brousse FC, Mc Knight SL, Wolberger C (1998) The structure of GABP alpha/beta: an ETS domain-ankyrin repeat heterodimer bound to DNA. Science 279:1037-1041
3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IP, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235-242
4. Brotherton DH, Dhanaraj V, Wick S, Brizuela L, Domaille PJ, Volyyanik E, Xu X, Parisini E, Smith BO, Archer SJ, Serrano M, Brenner SL, Blundell TL, Lane ED (1998) Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19NK4d. Nature 395:244-25021
5. Cresswell P (1994) Assembly, transport and function of MHC class II molecules. Annu Rev Immunol 12:259-293
6. DeSandro AM, Nagarajan UM, Boss JM (2000) Associations and interactions between bare lymphocyte syndrome factors. Mol Cell Biol 20:6587-6599
7. Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W (1997) RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency. EMBO J 16:1045-1055
8. Griscelli C, Fischer A, Grospierre B, Durandy A, Bremard C, Charron, Dvilmer E, Virelizer JL (1984) Clinical and immunological aspects of combined immunodeficiency with defective expression of HLA antigens. Excerpta Medica, Amsterdam
9. Griscelli C, Lisowska-Grospierre B, Mach B (1993) Combined immunodeficiency with defective expression in MHC class II genes. In: Rosen FS, Seligman M (eds) Immunodeficiencies. Harwood Academic, Chur, Switzerland, pp 141-154
10. Hasegawa SL, Boss JM (1991) Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters. Nucleic Acids Res 19:6269-6276
11. Klein C, Lisowska Grospierre B, LeDeist F, Fischer A, Griscelli C (1993) Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 123:921-928
12. Lisowska-Grospierre B, Fondaneche MC, Rols MP, Griscelli C, Fischer A (1994) Two complementation groups account for most cases of inherited MHC class II deficiency. Hum Mol Genet 3:953-958
13. Louis-Plence P, Moreno CS, Boss JM (1997) Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multi-protein complex on the conserved regulatory regions of HLA class II genes. J Immunol 159:3899-3909
14. Mach B, Steimle V, Martinez-Soria E, Reith W (1996) Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 14:301-331
15. Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W (1998) A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet 20:273-277
16. Nagarajan UM, Louis-Plence P, DeSandro A, Nilsen R, Bushey A, Boss JM (1999) RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10: 153-162
17. Nagarajan UM, Peijnenburg A, Gobin SJ, Boss JM, van den Elsen PJ. (2000) Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. J Immunol 164:3666-3674
18. Nakrep N, Jabrane-Ferrat N, Peterlin MB (2000) Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex. Mol Cell Biol 20:4455-4461
19. Nekrep N, Geyer M, Jabranne-Ferrat N, Peterlin MB (2001) Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome. Mol Cell Biol 21:5566-76
20. Peretti M, Villard J, Barras E, Zufferey M, Reith W (2001) Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP. Mol Cell Biol 21:5699-709
21. Steimle V, Otten LA, Zufferey M, Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146
22. Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, Reith W (1995) A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9:1021-1032
23. Wiszniewski W, Fondaneche MC, Lambert N, Masternak K, Picard C, Notarangelo L, Schwartz K, Bal J, Reith W, Alcaide C, de Saint B, Fischer A, Lisowska-Grospierre B (2000) Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics 51:261-267